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An abnormal ratio between Na + and K+ conductances seems to be the 
cause for the depolarization and paralysis of skeletal muscle in primary hy-
pokalemic periodic paralysis. Recently we have shown that the "K+ channel 
opener" cromakalim hyperpolarizes mammalian skeletal muscle fibers. Now 
we have studied the effects of this drug on the twitch force of muscle biop-
si es from normal and diseased human skeletal muscle. Cromakalim had lit-
tle effect on the twitch force of normal muscle whereas it strongly improved 
the contraction force of fibers trom patients suffering trom hypokalemic pe-
riodic paralysis. Recordings of intracellular K+ and CI- activities in human 
muscle and isolated rat soleus muscle support the view that cromakalim 
enhances the membrane K+ conductance (gK+). These data indicate that 
"K+ channel openers" may have a beneticial effect in primary hypokalemic 
periodic paralysis. 
Key words: cromakalim • inotropic effect • intracellular ion activities. skele-
tal muscle, human. periodic paralysis 
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ENHANCEMENT OF K+ CONDUCTANCE 
IMPROVES IN VITRO THE 
CONTRACTION FORCE OF SKELETAL 
MUSCLE IN HYPOKALEMIC 
PERIODIC PARALYSIS 
PETER GRAFE, MD, STEFAN QUASTHOFF, MICHAEL STRUPP, MD, 
and FRANK LEHMANN-HORN, MD 
There is good evidence that a depolarization of 
the muscle fiber membrane causes the loss of con-
tractility in primary hypokalemic periodic paraly-
sis (for review see Refs. 5 and 15). The pathophys-
iological basis for this disease seems to be an 
abnormal ratio in the relative conductances of 
Na + and K + .13.15 Investigations on excised exter-
nal intercostal muscle fibers revealed an unusual 
high Na + conductance and fiber depolarization in 
primary hypokalemic periodic paralysis. 14 Based 
on these findings one would expect that an lll-
crease in membrane K + conductance (gK +) 
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gK+ and Contraction Force 
should induce a membrane repolarization and 
an increase in muscle force in the periodic paral-
YSIS. 
Recently, we have found that drugs known to 
enhance gK+ in smooth and cardiac muscle (for 
review see Refs. 4 and 8) exert a similar action also 
on human skeletal muscle. 12 .18 Here we re port 
about the effects of the "K + channel opener" cro-
makaJim on the twitch force. of normal and dis-
eased isolated human skeletal muscle. The data 
show that cromakalim strongly improves the 
muscle strength of fibers from patients with pri-
mary hypokalemic periodic paralysis, whereas 
no effect on twitch force was found in control 
muscle. The experiments were supplemented 
with measurements of intracellular K+ and Cl-
activities in human and rat muscle fibers in 
order to gain more insight into the pathophysiol-
ogy of the disease and the mechanisms under-
lying the effects of cromakalim on skeletal 
muscle. 
MATERIALS AND METHODS 
The experiments were performed on biopsies of 
human skeletal muscle. 10. I 1 Specimens of fiber 
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segments (4-6 cm long) were dissected from bi-
ceps brachii, deltoid, vastus medialis or vastus lat-
eralis muscles under local anesthesia. Such fiber 
segments were obtained from (1) patients who 
consented that a muscle biopsy be carried out for 
the in vitro diagnosis of susceptibility to malignant 
hyperthermia; (2) patients who required a musc1e 
biopsy for clinical diagnosis; and (3) patients with 
a known neuromuscular disease who consented to 
have a muscle biopsy for experimental reasons 
only. All procedures were in accordance with the 
Helsinki convention and the Ethics Committee of 
the Technical University of Munich. Intracellular 
ion activities were also measured in fibers from 
isolated rat soleus muscle. 
The preparations were transferred to a per-
spex chamber (volume 2 mL, ftow rate 6.5 mlJ 
min) and superfused at 36°C with a solution of the 
following composition3 (in mmol/L): NaCI 107.7; 
CaCL2 1.53; KCI 3.48; MgS04 0.69; NaHC03 
26.2; NaH2P04 1.67; Na-glucuronate 9.64; glu-
cose 5.5; sucrose 7.6 (bubbled with 95% O2/5% 
CO2 ; pH 7.4). Micro-electrodes were drawn on a 
Brown Flaming micropipette puller (Sutter Instru-
ments, San Rafael, CA, USA). Single-barrelled 
electrodes had tip diameters below 0.2 !-Lm (filling 
solution 3 mol/L KCl, resistance 40-60 MOhm). 
The methods for the construction and calibration 
of the double-barrelled ion sensitive micro-elec-
trodes (tip size 1.0-1.5 !-Lm) are described in detail 
elsewhere. 1 The following combinations of ion-
exchanger, backfilling solution, and reference so-
lution were used: K + -sensitive micro-electrodes 
(Corning 477317, 200 mmol/L KCI, 1 mol/L 
Mg2+ acetate); CI--sensitive micro-electrodes (WP 
Instruments IE-170, 200 mmol/L KCI, 0.5 mol/L 
K+ sulfate). For the measurement of contrac-
tion force, a muscle fiber bundle was suspended 
in the perspex chamber with one end fixed and 
the other end fastened to astrain gauge (Hot-
tinger Baldwin, Darmstadt, FRG). Silver plates 
on both sides of the preparation were used 
for direct (Hfield") stimulation. Supramaximal sin-
gle square voltage pulses (2 msec duration, 
100 V stimulus strength) were applied every 10 
sec. 
Drugs were applied via the bathing solution. 
Glibenclamide was obtained from Hoechst (Frank-
furt, FRG); cromakalim (BRL 34915) was a gift 
from Beecham Pharmaceuticals (Gronau, FRG). 
Stock solutions (100 mmollL cromakalim, 10 
mmol/L glibenclamide) were prepared in dimethyl 
sulfoxide (DMSO). DMSO did not mimic the ef-
fects of cromakalim or glibenclamide. 
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RESULTS 
Effects of Cromakalim on Intracellular K+ Activity. 
The hyperpolarizing effect of cromakalim on hu-
man and also rat skeletal muscle was accompanied 
by a small decrease in the intracellular K +- activity 
(aKi ). Fig. 1 gives typical examples of the measure-
ments of aKj in human and rat skeletal musc1e 
cells. The baseline level of aKi of this control hu-
man muscle fiber, which had a resting membrane 
potential (Ern) of -70 mV, was 95 mmol/L (Fig. 
lA). Addition of cromakalim to the bathing solu-
tion resulted in a membrane hyperpolarization of 
15 mV and a decrease in aKi from 95 to about 93 
mmol/L. The voltage difference between the K +- -
sensitive and the reference electrode (EDiff) was 
0.5 mV. This amplitude is only a little higher than 
the noise level of our K +--sensitive micro-elec-
trodes. Therefore, cromakalim-induced changes 
in aKi were elose to the detection limit of the 
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FIGURE 1. Effects of cromakalim on intraceUu!ar K+ activity 
(aKi) and membrane potential (Ern) of a fiber in a normal human 
skeletal muscle segment (A) and in an isolated rat soleus mus-
cle (8). EOiff is the difference between the voltage reading of the 
K+ -sensitive and the reference barrel of the double-barreUed 
ion-sensitive micro-electrode. Cromakalim was applied via the 
bathing solution du ring the times indicated by the bars. 
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musele fiber from an isolated rat soleus musele. In 
this case, cromakalim induced a membrane hyper-
polarization of 10m V; aK j decreased from 93 to 
about 91 mmol/L. In summary, application of cro-
makalim resulted in a small decrease in aK j of hu-
man and rat skeletal musele fibers. A quantitative 
analysis of this effect is summarized in Table 1. 
EHeets of Cromakalim on Intraeellular CI- Actlvity. 
Cromakalim induced a decrease in intracellular 
CI- activity (aCI) of human and rat skeletal mus-
ele. Figure 2 illustrates an example of this effect. 
A relatively blunt double-barrelled CI--sensitive 
micro-electrode (tip diameter 1.5 tJ-m) was used in 
this experiment (rat soleus musele). Fiber impale-
ments with such electrodes resulted in recordings 
of low membrane potentials and relatively high 
aCl j • The effect of cromakalim on these fibers was 
a strong hyperpolarization (-20 mV or more) ac-
companied by a decrease in aCl j . Table 1 summa-
rizes the recordings of aCl j in rat and human fi-
bers before and during the application of 
cromakalim. 
Hypokalemic Periodic Paralysis. Musele speci-
mens were obtained from 4 patients with hy-
pokalemic periodic paralysis. Fiber segments of 
these museles had membrane potentials less nega-
tive than control values in solutions with normal 
extracellular K+ concentration (3.5 mmol/L). The 
average membrane potential obtained with single-
barrelIed electrodes in 16 fibers of 4 control mus-
eles was -80.7 ± 5.3 mV (mean ± SD); 17 fibers 
from 4 patients with hypokalemic periodic paraly-
sis had an average Ern of -71 ± 6.2 mV. The 
lower membrane potentials of the affected fibers 
are, however, not due to a decreased K+ equilib-
rium potential (EK ) since an aK j of 93.1 ± 1.6 
mmol/L (mean ± SD, n = 5 fibers in 2 museles) 
was found. 
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FIGURE 2. Effects of cromakalim on intracellular CI- activity 
(aCl;) and membrane potential (Ern) of a museie fiber from an 
isolated rat soleus museie. Cromakalim was applied via the 
bathing solution during the time indicated by the bar. 
Cromakalim induced a strong hyperpolariza-
tion in musele fibers from patients with hypo kale-
mic periodic paralysis. This is illustrated in Fig. 3. 
The fiber was impaled with a double-barrelled 
K+ -sensitive micro-electrode. At the beginning of 
the recording (solution with 3.5 mmoVL (K+]e) a 
resting potential of - 62 mV and an EK of - 95 
m V was found. The membrane depolarized fur-
ther and the difference between Ern and EK in-
creased when [K+]e in the bathing solution was re-
duced to 1 mmol/L. (A membrane depolarization 
upon lowering of (K +]e is a characteristic observa-
tion in isolated skeletal musele fibers from patients 
with hypokalemic periodic paralysis. 14) In this sit-
uation, the application of cromakalim resulted in a 
reversible membrane hyperpolarization of 35 mV. 
Later on, [K+]e was raised to 3.5 mmol/L. This 
produced only a slight increase in Ern' whereas aK j 
returned to its baseline level. Similar observations 
were made on another 4 fibers from 2 patients. 
Table 1. Effects of cromakalim (100 fLmol/L, application time 5 mini on membrane potential 
(Em), intracellular K+ activity (aKj), and intracellular CI- activity (aCI;) of fibers in rat soleus 
museie and human museie biopsies (control): 
Type of museie Em (mV) LlEm (mV) aKj (mmol/L) LlaKj (mmol/L) 
Rat, soleus (8;2) -72.2 ± 5.7 -6.8± 1.7 88.9 ± 4.6 -2.7 ± 0.6 
Human, control (12;2) -73.3 ± 4.8 -10.7 ± 5.3 96.1 ± 6.7 -2.8 ± 1.1 
aCl; (mmol/L) LlaCl j (mmol/L) 
Rat, soleus (11 ;3) -71.0 ± 6.2 -12.2 ± 3.5 9.2 ± 2.1 -1.3 ± 0.8 
Human, contral (6;2) -72.5 ± 7.3 -15.3 ± 10.4 8.0 ± 0.6 -2.0 ± 1.4 
'Mean values ± SO; the number 01 libers and museie preparations are given in parentheses. 
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FIGURE 3. Effects of cramakalim on intracellular K+ activity 
(aKi) and membrane potential (Ern) of a muscle fiber in a skele-
tal museie segment obtained fram a patient with hypokalemic 
periodic paralysis. [K+)e at the beginning of the recording was 
3.5 mmol/L. It was reduced to 1 mmol/L to imitate the clinical sit-
uation in which low levels of [K+)e are observed. EOiff is the dif-
ference between the voltage reading of the K+ -sensitive and the 
reference barrel of the double-barrelled K+ -sensitive micro-elec-
trode. Cromakalim was applied via the bathing solution during 
the time indicated by the bar. 
Twitch Force. The twitch force of segments of 
human skeletal muscle was tested by direct stimu-
lation of the muscle bundles (stimulus strength 
100 V, duration 2 msec). These experiments re-
vealed a differential effect of cromakalim. The 
drug preferentially increased the twitch force of 
fiber bundles from patients with hypokalemic pe-
riodic paralysis but not from controls. An example 
of such recordings is illustrated in Fig. 4. The reg-
istration in part A shows the effect of cromakalim 
on the twitch force of a control muscle. There was 
a relatively high contraction force in the standard 
solution. Application of the drug into the bathing 
solution did not increase the twitch force. In con-
trast, fiber bundles from patients with hypokale-
mjc periodic paralysis exerted little (sometimes no) 
twitch force in the normal bathing solution. How-
ever, cromakalim increased the contraction force 
of these muscles several times (Fig. 4B). This ef-
fect was only slowly reversible. After a lO-minute 
application of cromakalim, it took 30 minutes or 
more before the contraction force returned to the 
original value. All the measurements of twitch 
force before and during the application of cro-
makalim are summarized in Fig. 5. The preferen-
tial effect of cromakalim on the diseased muscle is 
clearly visible (note the logarithmic scale). Cro-
makalim had this effect in a bathing solution con-
taining 3.5 mmol/L [K+]e as wen as 1 mmol/L 
[K+]e· 
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FIGURE 4. Effects of cramakalim on the twitch force of a skele-
tal museie fiber bundle fram a contral person (A) and a patient 
suffering from hypokalemic periodic paralysis (8). The museies 
were stimulated supramaximally every 10 sec with a voltage 
pulse (100 V; stimulus duration 2 msec). Cromakalim was 
added to the bathing solution (3.5 mmol/L [K+)e) during the 
times indicated by the bars. The effect of cromakalim on the 
twitch force of the diseased museie was only slowly reversible 
(not iIIustrated, see text). 
Effects 01 Glibenclamide. Wehave shown 
previously12,18 that tolbutamide antagonizes the 
effect of cromakalim on human skeletal muscle. 
Now we have found that glibenclamide, another 
sulfonylurea compound, also blocks the effects of 
cromakalim. Fig. 6 illustrates this antagonism in a 
fiber from a patient suffering from hypokalemic 
periodic paralysis. The resting potential of this fi-
ber in a bathing solution of 1 mmoVL [K "t"]e was 
-50 mV. Cromakalim induced a membrane hy-
perpolarization of more than 40 mV. However, 
this effect was completely suppressed after 1 
j.Lmol/L glibenclamide was added to the cro-
makalim-containing solution. A similar observa-
tion was made on another 6 fibers, on which the 
effects of glibenclamide were explored. 
In four other experiments the effects of glib-
enclamide on the contraction force of normal and 
diseased human skeletal muscle biopsies were 
tested. We observed that glibenclamide itself had 
no effect on the twitch force. However, it com-
pletely suppressed or prevented the contraction 
force-facilitating effect of cromakalim on fiber 
bundles from patients with hypokalemic periodic 
paralysis (not illustrated). 
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FIGURE 5. Summary of the effects of cromakalim on the twitch force of 12 skeletal museie fiber bun-
dies obtained from 6 control persons and from 4 patients with hypokalemic periodic paralysis. The 
bundles were stimulated every 10 sec as illustrated in Figure 4. The values of the twitch force, which 
were taken before and 5-10 min after application of cromakalim, are shown. Note the logarithmic 
scale. 
DISCUSSION 
The present study shows that cromakalim (a) hy-
perpolarizes normal and diseased human skeletal 
musde fibers and (b) improves contraction force 
of fiber bundles from patients with primary hy-
pokalemic periodic paralysis. Cromakalim belongs 
to a new dass of drugs, called "K+ channel open-
ers", which activate K+ channels in a variety of 
smooth musde cells (for review see Refs. 4 and 8), 
in cardiac musde cells6 ,17 and in human skeletal 
musde cells. 12,18 One of the consequences of such 
an effect should be an efflux of intracellular K + 
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FIGURE 6. Glibenclamide antagonizes the effect of cromakalim. 
The figure shows a continuous recording of the membrane po-
tential (Ern) of a skeletal museie fiber from a patient with hy-
pokalemic periodic paralysis. [K+le in the bathing solution was 1 
mmol/L. Glibenclamide (1 J..LmoI/L) was added to the cro-
makalim-containing solution. 
gK+ and Contraction Force 
In fact, the measurements with K + -sensitive mi-
cro-electrodes in the present study revealed a dim-
inution of aK j • This finding, therefore, supports 
the idea that cromakalim enhances gK + also in 
skeletal muscle. Previously, this has been demon-
strated by means of current-voltage relation-
ships.18 The change in aCl j seen during the appli-
cation of cromakalim can be explained by the high 
CI- conductance of the muscle fiber membrane. 
This conductance leads to a passive CI- efflux 
when the membrane hyperpolarizes. Effects of 
cromakalim on ßuxes of sodium and calcium ions 
have not been investigated in the present study. 
However, it is unlikely that a decrease in the Na + 
conductance underlies the membrane hyperpolar-
ization seen in the presence of cromakalim. Such 
an effect should result in an increase rather than a 
decrease of aKj • Effects of cromakalim on the 
membrane Ca2+ conductance or Ca2+ transport 
mechanisms are possible and should be investi-
gated in future experiments. 
The experiments in which the effects of glib-
endamide were explored give an indication re-
garding the type of K + channel activated by cro-
makalim. Glibendamide seems to be a sr.ecific 
antagonist of ATP-dependent K+ channels7. 9 and 
it antagonizes the effect of cromakalim in cardiac 
muscle~,17 and also in human skeletal muscle 
(present study). It seems very likely, therefore, 
that cromakalim hyperpolarizes human skeletal 
musde by the opening of otherwise "silent", ATP-
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dependent K + channels. Other K + channels in 
skeletal musde, like the A-channel, delayed recti-
fier, and calcium-activated potassium channels are 
not antagonized by glibendamide.4 Therefore, we 
find it unlikely that the conductance of these 
channels is modulated by cromakalim although no 
direct experimental evidence exists. 
Cromakalim improved the contraction force of 
muscle fibers from patients with primary hy-
pokalemic periodic paralysis. Two mechanisms are 
probably involved in this effecL First, slow inacti-
vation of Na + channels is a possible mechanism 
for reduced excitability in musde fibers with low 
membrane potentials, e.g. in primary hypokalemic 
periodic paralysis. 16 This process is especially im-
portant because it operates around the resting 
membrane potential. Consequendy, the observed 
repolarization could restore simultaneously nor-
mal excitability and contraction force. The second 
mechanism by which the cromakalim-induced re-
polarization could improve twitch force is based 
on the voltage dependency of the transduction 
protein between excitation and contraction.9 Re-
cently, this protein has been identified as the dihy-
dropyridine receptor in the trans verse tubule 
membrane. It functions both as the voltage sensor 
for excitation-contraction coupling and as the 
slow calcium channel. 20 The pro tein is half inacti-
vated at a potential around -40 mV and can be 
reactivated by membrane repolarization.2 Taken 
these results together, it is likely that the mem-
brane repolarization induced by cromakalim (a) 
improves spread of excitation along the cell mem-
brane and (b) enhances indirecdy the release of 
calcium from the sarcoplasmic reticulum. 
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